Birdwatch Note
2024-10-02 18:18:43 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Исследования не подтверждают данный тезис https://www.healthline.com/health-news/ozempic-mounjaro-and-similar-drugs-dont-increase-risk-of-pancreatic-cancer
Written by 6A77AC3C7592D2718376D8C32FC4FD0024BF299771B64A450A1EC50344FBDC5C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1841407309286719910
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1841543351327129949
- noteId - 1841543351327129949
- participantId -
- noteAuthorParticipantId - 6A77AC3C7592D2718376D8C32FC4FD0024BF299771B64A450A1EC50344FBDC5C
- createdAtMillis - 1727893123836
- tweetId - 1841407309286719910
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Исследования не подтверждают данный тезис https://www.healthline.com/health-news/ozempic-mounjaro-and-similar-drugs-dont-increase-risk-of-pancreatic-cancer
Note Ratings
| rated at | rated by | |
| 2024-10-02 19:39:43 -0500 | Rating Details | |
| 2024-10-02 19:07:02 -0500 | Rating Details | |
| 2024-10-02 19:05:16 -0500 | Rating Details | |
| 2024-10-02 16:51:08 -0500 | Rating Details | |
| 2024-10-02 16:23:22 -0500 | Rating Details | |
| 2024-10-02 15:30:39 -0500 | Rating Details | |
| 2024-10-02 15:04:22 -0500 | Rating Details | |
| 2024-10-02 14:49:57 -0500 | Rating Details | |
| 2024-10-02 14:21:02 -0500 | Rating Details | |
| 2024-10-02 14:20:17 -0500 | Rating Details | |
| 2024-10-02 14:12:59 -0500 | Rating Details | |
| 2024-10-02 13:42:04 -0500 | Rating Details | |
| 2024-10-03 12:51:05 -0500 | Rating Details | |
| 2024-10-03 12:34:11 -0500 | Rating Details | |
| 2024-10-03 09:26:52 -0500 | Rating Details | |
| 2024-10-03 08:25:57 -0500 | Rating Details | |
| 2024-10-03 07:44:23 -0500 | Rating Details | |
| 2024-10-03 03:45:03 -0500 | Rating Details | |
| 2024-10-03 03:40:34 -0500 | Rating Details | |
| 2024-10-03 02:46:16 -0500 | Rating Details | |
| 2024-10-03 02:24:17 -0500 | Rating Details | |
| 2024-10-03 01:53:22 -0500 | Rating Details | |
| 2024-10-03 00:49:29 -0500 | Rating Details | |
| 2024-10-03 00:24:29 -0500 | Rating Details | |
| 2024-10-02 21:51:57 -0500 | Rating Details | |
| 2024-10-02 20:21:41 -0500 | Rating Details | |
| 2024-10-02 17:13:57 -0500 | Rating Details | |
| 2024-10-02 17:13:04 -0500 | Rating Details | |
| 2024-10-02 15:00:20 -0500 | Rating Details | |
| 2024-10-02 14:02:41 -0500 | Rating Details | |
| 2024-10-02 13:39:31 -0500 | Rating Details | |
| 2024-10-06 09:34:34 -0500 | Rating Details | |
| 2024-10-03 00:21:35 -0500 | Rating Details | |
| 2024-10-02 13:52:11 -0500 | Rating Details | |
| 2024-10-02 15:47:09 -0500 | Rating Details | |
| 2024-10-05 04:44:10 -0500 | Rating Details |